$0.06
-$0.02 (-25.00%) today
About Telo Genomics Corp. (TDSGF)
Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides TeloView-SMM application; TeloView, an analysis software platform for prediction of genomic instability. It has a collaboration agreement with the Mayo Clinic to validate its SMM tests for multiple myeloma. Telo Genomics Corp. is headquartered in Toronto, Canada.
- CEO
- Dr. Sabine Mai Ph.D.
- Employees
- 0
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Toronto, ON Canada
Key Statistics
- High Today
- $0.06
- Low Today
- $0.06
- Open Today
- $0.06
- Volume Today
- 0.0
- 52 Week High
- $0.18
- 52 Week Low
- $0.05
- Average Volume
- 566